Literature DB >> 2246893

Calcium antagonists retard extracellular matrix production in connective tissue equivalent.

R C Lee1, J A Ping.   

Abstract

Hypertrophic and keloid scars are characterized by the overproduction of extracellular matrix collagen and proteoglycans. Because cellular secretion of macromolecules is known to be a calcium-dependent process, we have examined the effect of calcium antagonists on the rate of incorporation of [3H]proline into protein and Na235SO4 into sulfated glycosaminoglycans. Experiments were carried out in vitro using uniaxially oriented mammalian fibroblast-populated collagen matrices which exhibit many histoarchitectural features of scar matrix. We observed that nifedipine and verapamil in sufficient concentrations inhibited the incorporation of proline into extracellular matrix protein. The concentration range studied was 1 to 100 microM. Cobalt chloride (200 microM) had a similar effect on proline incorporation, but enhanced the incorporation of sulfate into extracellular matrix glycosaminoglycans. We conclude that cellular calcium metabolism appears to regulate extracellular matrix production and that hypertrophic disorders of wound healing may respond to therapy with calcium antagonist drugs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2246893     DOI: 10.1016/0022-4804(90)90197-a

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  18 in total

Review 1.  Therapy of auricular keloids: review of different treatment modalities and proposal for a therapeutic algorithm.

Authors:  K Froelich; R Staudenmaier; N Kleinsasser; R Hagen
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-07-13       Impact factor: 2.503

Review 2.  Contemporary Review of Peyronie's Disease Treatment.

Authors:  Edward Capoccia; Laurence A Levine
Journal:  Curr Urol Rep       Date:  2018-05-17       Impact factor: 3.092

Review 3.  [Keloid and hypertrophic scar treatment modalities. An update].

Authors:  L K Branski; H O Rennekampff; P M Vogt
Journal:  Chirurg       Date:  2012-09       Impact factor: 0.955

Review 4.  2013-2014 updates in Peyronie's disease management.

Authors:  Benjamin A Sherer; Krishnan Warrior; Laurence A Levine
Journal:  Curr Urol Rep       Date:  2014-12       Impact factor: 3.092

5.  [Hyperplastic scars and keloids. Part I: basics and prevention].

Authors:  A Baisch; F Riedel
Journal:  HNO       Date:  2006-11       Impact factor: 1.284

6.  Wound healing potential of topical amlodipine in full thickness wound of rabbit.

Authors:  Ali Asghar Hemmati; Hoda Mojiri Forushani; Hossein Mohammad Asgari
Journal:  Jundishapur J Nat Pharm Prod       Date:  2014-06-16

7.  Role of verapamil in preventing and treating hypertrophic scars and keloids.

Authors:  Ru Wang; Yu Mao; Zhenyu Zhang; Zhengyong Li; Junjie Chen; Ying Cen
Journal:  Int Wound J       Date:  2015-05-12       Impact factor: 3.315

8.  Calcium channel blockers in reduction of epidural fibrosis and dural adhesions in laminectomy rats.

Authors:  Zhiqiang Wang; Yuguang Wang; Peng Xie; Wei Liu; Sai Zhang
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-12-24

9.  Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study.

Authors:  M Shirazi; A R Haghpanah; M Badiee; M A Afrasiabi; S Haghpanah
Journal:  Int Urol Nephrol       Date:  2009-02-06       Impact factor: 2.370

10.  Nitric Oxide Produced by the Antioxidant Activity of Verapamil Improves the Acute Wound Healing Process.

Authors:  Yu Na Han; Yoon Jae Lee; Ki Joo Kim; Su Jin Lee; Jang Youn Choi; Suk-Ho Moon; Jong Won Rhie
Journal:  Tissue Eng Regen Med       Date:  2021-01-29       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.